Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/27887
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community
Author(s): Johnson, Chris F
Ali Nassr, Ola
Harpur, Catherine
Kenicer, David
Thom, Alex
Akram, Gazala
Keywords: Benzodiazepines
Patient Discharge
Practice Patterns, Physicians'
Psychiatric Department, Hospital
Psychiatry
Retrospective Studies
United Kingdom
Issue Date: 30-Sep-2018
Date Deposited: 2-Oct-2018
Citation: Johnson CF, Ali Nassr O, Harpur C, Kenicer D, Thom A & Akram G (2018) Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community. Pharmacy Practice, 16 (3), Art. No.: 1256. https://doi.org/10.18549/PharmPract.2018.03.1256
Abstract: Background: Benzodiazepine and z-hypnotic prescribing has slowly decreased over the past 20 years, however long-term chronic prescribing still occurs and is at odds with prescribing guidance. Objectives: To identify the pattern of benzodiazepine and z-hypnotic prescribing in psychiatric inpatients at discharge and 12 months post-discharge. Methods: Retrospective observational longitudinal cohort study of patients admitted to two adult psychiatric wards between June and November 2012 (inclusive) who were discharged with a prescription for a benzodiazepine or z-hypnotic drug. Routinely collected prescription data available from NHS Scotland Prescribing Information System was used to identify and follow community prescribing of benzodiazepine and z-hypnotics for a 12 month period post-discharge. Data were entered in Excel® and further analysed using SPSS 23. Ethical approval was not required for this service evaluation however Caldicott Guardian approval was sought and granted. Results: Eighty patients were admitted during the study period however only those patients with a single admission were included for analysis (n=74). Thirty per cent (22/74) of patients were prescribed a benzodiazepine or z-hypnotics at discharge; 14 of whom received ‘long-term’ benzodiazepine and z-hypnotics i.e. continued use over the 12 month period. Seven patients received a combination of anxiolytics and hypnotics (e.g., diazepam plus temazepam or zopiclone). Long-term use was associated with a non-significant increase in median benzodiazepine or z-hypnotic dose, expressed as diazepam equivalents. Conclusions: One in three patients were prescribed a benzodiazepine or z-hypnotics at discharge with 1 in 5 receiving continuous long-term treatment (prescriptions) for 12 months post-discharge. As chronic long-term B-Z prescribing and use still remains an issue, future strategies using routine patient-level prescribing data may support prescribers to review and minimise inappropriate long-term prescribing.
DOI Link: 10.18549/PharmPract.2018.03.1256
Rights: Article distributed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) license (https://creativecommons.org/licenses/by-nc-nd/3.0/).
Licence URL(s): http://creativecommons.org/licenses/by-nc-nd/3.0/

Files in This Item:
File Description SizeFormat 
Johnson-etal-PharmPractice-2018.pdfFulltext - Published Version660.1 kBAdobe PDFView/Open



This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.